Genomic insights into clinical non-O1/non-O139 Vibrio cholera e isolates in Japan
- PMID: 40552807
- PMCID: PMC12323619
- DOI: 10.1128/spectrum.00175-25
Genomic insights into clinical non-O1/non-O139 Vibrio cholera e isolates in Japan
Abstract
Non-O1/non-O139 Vibrio cholerae (NOVC) causes sporadic intestinal infections and systemic symptoms. Recently, global warming has led to an increase in NOVC infections; however, there have been no reports on the genomic analysis of clinical NOVC isolates in Japan, and the molecular understanding of NOVC remains inadequate. We identified three cases of NOVC infection in Nagoya, Japan, in 2020 and performed genomic analysis to reveal the molecular characteristics of these isolates and compared them with those of previously reported clinical cases. Phylogenetic analysis revealed high diversity. This result indicates that the three cases were sporadic within the area over a short period of time from multiple contaminated sources. However, most clinical isolates carried virulence factor genes encoding El Tor type hemolysin, type VI secretion system (T6SS), and repeats-in-toxin toxin, and approximately half of the isolates carried nanH encoded on VPI-2, as well as the type III secretion system (T3SS). Additionally, detailed whole-genome sequencing (WGS) analysis revealed various types of T3SS, T6SS, VPI-2, and VSP-2. Variations in the number of Rep1 units of VopM were observed in the T3SS of the NOVC isolates in this study. The T6SS type identified in this study consisted of a large cluster and auxiliary clusters, showing diversity among the NOVC isolates. We recommend continued monitoring of clinical NOVC isolates as horizontal transmission along with host and environmental recombination may lead to changes in virulence.IMPORTANCEAlthough reports of non-O1/non-O139 Vibrio cholerae (NOVC) infections are rare, their actual incidence remains uncertain. This is partly due to nonspecific symptoms, the absence of a surveillance system in most countries including Japan, and the lack of appropriate laboratory culture techniques. However, NOVCs in the environment are increasing due to global warming, and the risk of NOVC infections is increasing. In this study, we conducted a comprehensive genomic analysis of clinical NOVC isolates from a city in Japan and compared their virulence factor profiles with those of previously reported clinical isolates using whole-genome sequencing (WGS). This result indicates that some sporadic cases have occurred in the area, suggesting that there are multiple sources of NOVC infection. The accumulation of such data will enhance our understanding of the pathogenicity of NOVCs and improve diagnostic accuracy.
Keywords: T3SS; T6SS; non-O1/non-O139 Vibrio cholerae (NOVC); virulence factor gene; whole-genome sequencing.
Conflict of interest statement
The authors declare no conflict of interest.
Figures



Similar articles
-
German coasts harbor non-O1/non-O139 Vibrio cholerae with clinical virulence gene profiles.Infect Genet Evol. 2024 Jun;120:105587. doi: 10.1016/j.meegid.2024.105587. Epub 2024 Mar 20. Infect Genet Evol. 2024. PMID: 38518953
-
Genetic approach toward linkage of Iran 2012-2016 cholera outbreaks with 7th pandemic Vibrio cholerae.BMC Microbiol. 2024 Jan 22;24(1):33. doi: 10.1186/s12866-024-03185-9. BMC Microbiol. 2024. PMID: 38254012 Free PMC article.
-
Clinical and Environmental Vibrio cholerae Non-O1, Non-O139 Strains from Australia Have Similar Virulence and Antimicrobial Resistance Gene Profiles.Microbiol Spectr. 2023 Feb 14;11(1):e0263122. doi: 10.1128/spectrum.02631-22. Epub 2023 Jan 23. Microbiol Spectr. 2023. PMID: 36688638 Free PMC article.
-
Global status of antimicrobial resistance among environmental isolates of Vibrio cholerae O1/O139: a systematic review and meta-analysis.Antimicrob Resist Infect Control. 2022 Apr 25;11(1):62. doi: 10.1186/s13756-022-01100-3. Antimicrob Resist Infect Control. 2022. PMID: 35468830 Free PMC article.
-
Estimating the proportion of clinically suspected cholera cases that are true Vibrio cholerae infections: A systematic review and meta-analysis.PLoS Med. 2023 Sep 14;20(9):e1004286. doi: 10.1371/journal.pmed.1004286. eCollection 2023 Sep. PLoS Med. 2023. PMID: 37708235 Free PMC article.
References
-
- Yamai S, Okitsu T, Shimada T, Katsube Y. 1997. Distribution of serogroups of Vibrio cholerae non-O1 non-O139 with specific reference to their ability to produce cholera toxin, and addition of novel serogroups. Kansenshogaku Zasshi 71:1037–1045. doi: 10.11150/kansenshogakuzasshi1970.71.1037 - DOI - PubMed
-
- Arteaga M, Velasco J, Rodriguez S, Vidal M, Arellano C, Silva F, Carreño LJ, Vidal R, Montero DA. 2020. Genomic characterization of the non-O1/non-O139 Vibrio cholerae strain that caused a gastroenteritis outbreak in Santiago, Chile, 2018. Microb Genom 6:e000340. doi: 10.1099/mgen.0.000340 - DOI - PMC - PubMed
-
- Dziejman M, Serruto D, Tam VC, Sturtevant D, Diraphat P, Faruque SM, Rahman MH, Heidelberg JF, Decker J, Li L, Montgomery KT, Grills G, Kucherlapati R, Mekalanos JJ. 2005. Genomic characterization of non-O1, non-O139 Vibrio cholerae reveals genes for a type III secretion system. Proc Natl Acad Sci USA 102:3465–3470. doi: 10.1073/pnas.0409918102 - DOI - PMC - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources